Chemical activators of ZFP758 include a variety of compounds that can initiate a cascade of intracellular events leading to the activation of the protein. Forskolin, for example, directly stimulates adenylate cyclase, thereby increasing the cellular levels of cyclic AMP (cAMP), which in turn activates protein kinase A (PKA). PKA is known for its ability to phosphorylate various proteins, and in this context, it can phosphorylate ZFP758, leading to the protein's activation. Similarly, Ionomycin acts by increasing intracellular calcium levels, which can activate calmodulin-dependent kinases. These kinases, upon activation, have the ability to phosphorylate target proteins such as ZFP758, thereby promoting its activation. Phorbol 12-myristate 13-acetate (PMA) is a potent activator of protein kinase C (PKC), which phosphorylates serine and threonine residues on target proteins, and this can directly lead to the activation of ZFP758. Thapsigargin contributes to ZFP758 activation by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), causing an increase in cytosolic calcium levels, which can activate kinase pathways that phosphorylate and activate ZFP758.
Further to these mechanisms, Calyculin A and Okadaic Acid maintain the phosphorylation state of proteins by inhibiting protein phosphatases 1 and 2A, which could result in sustained activation of ZFP758. Zinc Pyrithione supplies zinc ions, which can induce a conformational change in certain zinc-finger proteins, potentially leading to the activation of ZFP758. Piceatannol, through its inhibition of certain kinases, can alter the phosphorylation landscape within the cell, which in turn may lead to the activation of ZFP758. Staurosporine, although widely known as a kinase inhibitor, at low concentrations can activate certain kinases, which then may phosphorylate and activate ZFP758. Spermine NONOate releases nitric oxide that activates guanylate cyclase, increasing cGMP levels, which can then activate protein kinases that phosphorylate ZFP758. Dibutyryl-cAMP, a membrane-permeable cAMP analog, activates PKA, and this kinase can phosphorylate ZFP758. Lastly, Bromo-ADP-ribose may act as a substrate for ADP-ribosylation, a post-translational modification that can activate ZFP758.
Share
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium concentration, activating calmodulin-dependent kinases that may phosphorylate ZFP758. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Directly activates PKC which can phosphorylate and thereby activate ZFP758. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibits SERCA leading to increased cytosolic calcium, potentially activating kinases that phosphorylate ZFP758. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Inhibits protein phosphatases 1 and 2A, maintaining phosphorylation states which could keep ZFP758 activated. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibits protein phosphatases leading to increased protein phosphorylation, potentially maintaining ZFP758 activation. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Supplies zinc ions which may induce a conformational change, activating ZFP758. | ||||||
Piceatannol | 10083-24-6 | sc-200610 sc-200610A sc-200610B | 1 mg 5 mg 25 mg | $51.00 $71.00 $199.00 | 11 | |
Inhibits certain kinases, altering phosphorylation landscape which may lead to ZFP758 activation. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
At low concentrations can paradoxically activate kinases that may phosphorylate and activate ZFP758. | ||||||
Spermine NONOate | 136587-13-8 | sc-202816 sc-202816A | 5 mg 25 mg | $53.00 $196.00 | 5 | |
Releases nitric oxide which activates guanylate cyclase, raising cGMP levels that could activate ZFP758. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
cAMP analog that activates PKA, which could then phosphorylate ZFP758. | ||||||